Array Biopharma (ARRY) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.41 +2.35%
EPS Growth %: -52.0%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
FOMI, FLES, IMMR, More
EPS Growth %: -52.0%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
FOMI, FLES, IMMR, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q1 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $16.2 million versus the consensus estimate of $14.02 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- Kimball Electronics buys European medical CDMO for ~$103M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
